RT Journal Article
SR Electronic
T1 Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.03.20243105
DO 10.1101/2020.12.03.20243105
A1 Akbar, Naveed
A1 Forteath, Calum
A1 Hussain, Muhammad S.
A1 Reyskens, Kathleen
A1 Belch, Jill J. F.
A1 Lang, Chim C.
A1 Mordi, Ify
A1 Bhalraam, U
A1 Arthur, J. Simon C.
A1 Khan, Faisel
YR 2020
UL http://medrxiv.org/content/early/2020/12/04/2020.12.03.20243105.abstract
AB Inflammation promotes endothelial dysfunction. Using translational vascular function testing in myocardial Infarction patients, a situation where inflammation is prevalent, and knock-out (KO) mouse models we demonstrate a role for mitogen-activated-protein-kinases (MAPKs) in endothelial dysfunction. Myocardial infarction significantly lowers mitogen and stress kinase 1/2 (MSK1/2) expression in peripheral blood mononuclear cells and diminished endothelial function. To further understand the role of MSK1/2 in vascular function we developed in vivo animal models to assess vascular responses to vasoactive drugs using laser Doppler imaging. Genetic deficiency of MSK1/2 in mice increased plasma levels of pro-inflammatory cytokines and promoted endothelial dysfunction, through attenuated production of nitric oxide (NO), which were further exacerbated by cholesterol feeding. MSK1/2 are activated by toll-like receptors through MyD88. MyD88 KO showed preserved endothelial function and reduced plasma cytokine expression, despite significant hypercholesterolemia. MSK1/2 kinases interact with MAPK-activated proteins 2/3 (MAPKAP2/3), which limit cytokine synthesis. Cholesterol-fed MAPKAP2/3 KO mice showed reduced plasma cytokine expression and preservation of endothelial function. MSK1/2 plays a significant role in the development of endothelial dysfunction and may provide a novel target for intervention to reduce vascular inflammation. Selective activation of MSK1/2 could reduce pro-inflammatory responses and preserve endothelial function before development of significant vascular disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Medical Research Council, TENOVUS Scotland, and the Anonymous Trust, University of Dundee.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Investigations conformed to the principles outlined in the Declaration of Helsinki and local ethical approval was granted by review boards at the University of Dundee. All experiments were performed under UK Home Office Licences and conducted according to the Animals Scientific Procedures Act 1986 (UK) and directive 2010/63/EU of the European Parliament guidelines on the protection of animals used for scientific purposes. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/aAMIAcute myocardial infarctionAUArbitrary unitAUCArea under CurveBMIBody mass indexCVDCardiovascular diseaseDMSODimethyl sulfoxideEDTAEthylenediaminetetraacetic acidEGTAEthylene glycol tetraacetic acidFBSFoetal bovine serumFMDFlow mediated dilationGTNGlyceryl trinitrateHDLHigh-density lipoproteinHVHealthy volunteersIL-interleukin-KOKnock-outLDLLow density lipoproteinLPSLipopolysaccharideLVLeft ventricleMAPKMitogen activate protein kinaseMAPKAPKMitogen activate protein kinase-activated kinaseMSKMitogen and stress kinaseMSRUMedical school resource unitNONitric oxideNOSNitric oxide synthasePBMCPeripheral blood mononuclear cellPBSPhosphate buffered salinePCIPercutaneous coronary interventionPCRPolymerase chain reactionPEPhenylephrineROIRegion of interestRPMRounds per minuteSDStandard deviationSNPSodium nitroprussideSTEMIST-Elevation Myocardial InfarctionTLRToll-like receptorTNFTumour necrosis factorWTWild-type